Keyphrases
5-hydroxytryptamine3 Receptor
12%
Adjusted Odds Ratio
20%
Adverse Effects
15%
AIDS/HIV
29%
Alzheimer's Dementia
12%
Alzheimer's Disease
35%
Antidepressants
32%
Antipsychotics
18%
Antiretroviral Therapy
13%
Body Mass Index
13%
Breast Cancer
17%
Chronic Conditions
20%
Chronic Obstructive Pulmonary Disease
12%
Clozapine
22%
Comorbidity
29%
Confidence Interval
39%
Cornea
17%
Depression Treatment
24%
Diabetes
61%
Diabetes Management
12%
Diabetic
20%
Drug Interactions
34%
Ethanol
13%
Extracellular Matrix
14%
FK228
14%
Glaucoma
42%
Global Burden of Disease 2019
12%
Haloperidol
40%
Health Care Costs
16%
Health-related Quality of Life
14%
Healthcare Expenditure
32%
Healthcare Professionals
17%
Healthcare Utilization
19%
Healthy Volunteers
15%
Histone Deacetylase Inhibitor (HDACi)
21%
HIV Patients
26%
Hospitalization
15%
Human Corneal Fibroblasts
15%
Hypertension
18%
Hypoxia
15%
Immunization
12%
Keratoconus
45%
Lopinavir
12%
Lung
33%
Medicaid
31%
Medicaid Beneficiaries
17%
Medical Expenditure Panel Survey
12%
Medicare
22%
Medicare Beneficiaries
50%
Medication Adherence
12%
Mental Illness
15%
Meta-analysis
28%
Metabolism
24%
Metabotropic Glutamate Receptor 5 (mGluR5)
25%
Mouse Model
25%
Mycoplasma
29%
Mycoplasma Pulmonis
22%
Nanoparticles
26%
Negative Allosteric Modulator
35%
Neurodegenerative Diseases
15%
Non-Hispanic White
14%
Odds Ratio
21%
Older Adults
32%
Optic Nerve
15%
Osteoarthritis
16%
Oxidative Damage
15%
Oxidative Stress
50%
Parkinson's Disease
19%
Pharmacist
53%
Pharmacodynamics
15%
Pharmacokinetics
53%
Pharmacotherapy
14%
Pharmacy
20%
Pharmacy Students
24%
Plasma Concentration
21%
Polypharmacy
12%
Population Pharmacokinetics
13%
Prescription Drugs
17%
Respiratory Disease
14%
Retina
19%
Retinal Ganglion Cells
18%
Retrospective Cohort Study
16%
Risk Factors
21%
Ritonavir
16%
Schizophrenic Patients
27%
Small Molecules
17%
Staphylococcus Aureus
14%
Statins
14%
Structure-activity Relationship
12%
Student Pharmacists
15%
Systematic Meta-analysis
22%
Thailandepsin A
16%
Tolerability
14%
Type 1 Diabetes Mellitus (T1DM)
33%
Type 2 Diabetes Mellitus (T2DM)
30%
United States
71%
Vancomycin
13%
Veterans Health Administration
15%
Warfarin
13%
West Virginia
22%
Pharmacology, Toxicology and Pharmaceutical Science
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
36%
Adenosine Triphosphate
10%
Adverse Event
23%
Allosteric Modulator
36%
Alzheimer's Disease
23%
Antibacterial Activity
10%
Antibiotic Agent
12%
Antidepressant
32%
Antidiabetic Agent
8%
Antiinfective Agent
21%
Antioxidant
16%
Antipsychotic
16%
Arachidonic Acid
11%
Bioavailability
8%
Breast Cancer
11%
Carbon 14
14%
Chemotherapy
11%
Chronic Obstructive Lung Disease
15%
Chronic Pain
9%
Cigarette Smoke
9%
Clinical Trial
15%
Clostridium Difficile Infection
9%
Clozapine
20%
Cohort Study
16%
Combination Therapy
9%
Comorbidity
10%
Cross-Sectional Study
15%
CYP3A4
8%
Cytochrome P450
8%
Diabetes Mellitus
28%
Disease
65%
Doxorubicin
9%
Drug Development
12%
Drug Interaction
24%
Drug-Drug Interaction
13%
Epileptic Absence
10%
Escherichia coli
8%
Fibrosis
9%
Glaucoma
13%
Glutamate Receptor
8%
Histone Deacetylase Inhibitor
17%
HIV
62%
Human Immunodeficiency Virus Infection
12%
Hydrogen Peroxide
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
IC50
9%
Infection
35%
Infectious Agent
11%
Injury
13%
Keratoconus
25%
Leporidae
9%
Lopinavir Plus Ritonavir
9%
Major Depression
9%
Malignant Neoplasm
41%
Metabotropic Receptor
16%
Mouse
62%
Mouse Model
10%
Multiple Chronic Conditions
8%
Nanoparticle
39%
Neoplasm
18%
Nitric Oxide
10%
Non Insulin Dependent Diabetes Mellitus
14%
Normal Human
23%
Olanzapine
8%
Opiate
23%
Parkinson's Disease
14%
Penicillinase
13%
Pharmacodynamics
22%
Pharmacogenetics
9%
Pharmacokinetics
100%
Pharmacotherapy
24%
Placebo
8%
Polypharmacy
9%
Positive Allosteric Modulator
11%
Prescription Drug
27%
Prevalence
30%
Prostate Cancer
10%
Protein Kinase C
8%
Proteinase Inhibitor
12%
Reactive Oxygen Metabolite
12%
Receptor
30%
Reduced Haloperidol
26%
Ritonavir
19%
Selective Serotonin Reuptake Inhibitor
10%
Serotonin 3A Receptor
11%
Side Effect
14%
Sphingolipid
8%
Staphylococcus Aureus
17%
Statin (Protein)
13%
Structure Activity Relationship
20%
Symptom
14%
Tablet
8%
Tenofovir
8%
Therapeutic Drug Monitoring
14%
Tolerability
14%
Typical Antipsychotic
20%
Vaccination Policy
8%
Vancomycin
11%
Warfarin
10%
Wound Healing
9%